Eli Lilly to supply COVID-19 antibody therapy to low-income countries

13 October, 2020

Eli Lilly has announced an agreement with the Bill & Melinda Gates Foundation for potential supply of its experimental antibody treatments for COVID-19 to low and middle-income countries.

As part of the deal, Lilly said make antibody therapies available to lower-income countries prior to April 2021, but did not elaborate on the number of doses.

LATEST NEWS

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Countering Misinformation & Disinformation: Practical Training for Organizations

Practical skills to detect, verify, and respond across an evolving information landscape